Trevi Therapeutics, Inc. TRVI Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s share-based compensation arrangement by share-based payment award, options, expirations in period.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s share-based compensation arrangement by share-based payment award, options, expirations in period?
- Trevi Therapeutics, Inc. (TRVI) reported share-based compensation arrangement by share-based payment award, options, expirations in period of 0 in Q1 2026.
- What does share-based compensation arrangement by share-based payment award, options, expirations in period mean?
- The count of stock options that reached the end of their contractual term without being exercised, resulting in their expiration. This reflects the historical utilization of equity incentive plans and the potential for future dilution.